|Skip left side navigation and go to content||
NHLBI Small Business Program
Apply through PA-16-019 by March 21, 2016
The I-Corps™ at NIH program aims to accelerate the translation of biomedical research to the marketplace by providing entrepreneurship training to SBIR and STTR Phase I grantees. I-Corps™ teams participate in an Entrepreneurial Immersion course using a hypothesis-driven method of customer discovery to gain insights into issues associated with technology commercialization.
Learn more from the archived webinar.
Direct Phase II SBIR Grants to Support Biomedical Technology Development
Apply through PAR-14-088 by April 5, 2016
Notice Clarifying SBIR Direct-to-Phase II Eligibility Criteria: NOT-OD-HL-16-052
The NIH Direct-to-Phase II program will accept Phase II submissions regardless of the funding source for the Phase I-like proof of principle work on which the proposed Phase II research is based.
The Direct-to-Phase-II SBIR mechanism eliminates the need for the SBCs to propose additional small feasibility studies, if the technology is ready for the Phase II stage of development. The Direct-to-Phase II authority is not available to the STTR program.
If you’re interested in the Direct-to-Phase II program, check out what to include in your 12 page Commercialization Plan (in the SF424 application guide , pg I-129) and take a look at our presentation on “Writing Your Phase II Commercialization Plan”.
Tips on Your Commercialization Plan and Regulatory Strategy – watch the NHLBI Small Biz Hangouts.
Check out archived presentations
Learn more about the NHLBI Innovation Conferences.NHLBI is committed to connecting small businesses, angel investors, venture capitalists, strategic partners, and business leaders from the biotech and pharmaceutical industries in various regions of the country. Read about past conferences here.
Last Updated January 2016
2/8-2/9 – BIG CEO & Investor Conference - New York City, NY
2/14-2/17 – AUTM 2016 Annual Meeting - San Diego, CA
2/16 – Bioreactors for Reparative Medicine - Webinar
2/20-2/23 – Cardiovascular Research Technologies (CRT) 2016 - Washington, DC
3/9 – Boston Biotech Conferences - Boston, MA